4.4 Article

Proof-of-concept study to quantify changes in intestinal loads of KPC-producing Klebsiella pneumoniae in colonised patients following selective digestive decontamination with oral gentamicin

期刊

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.jgar.2022.04.010

关键词

Intestinal colonisation; Selective digestive decontamination; Antimicrobial resistance; KPC-producing Klebsiella pneumoniae; Bacterial load

资金

  1. Plan Estatal de I+ D+ I 2013-2016 [FIS PI16/01631]
  2. ISCIII-Subdireccion General de Evaluacion y Fomento de la Investigacion
  3. Fondo Europeo de Desarrollo Regional (FEDER)
  4. Plan Nacional de I+D+i 2013-2016
  5. Instituto de Salud Carlos III (ISCIII), Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Ciencia, Innovacion y Universidades, Spanish Network for Research in Infectious Diseases - European Development Regional Fund 'A way [RD16/0016/0008]
  6. Consejeria de Salud y Familias, Junta de Andalucia [RH-0065-2020I]

向作者/读者索取更多资源

This study developed a real-time quantitative PCR method to monitor the extent of intestinal colonisation by KPC-producing Klebsiella pneumoniae in colonised patients receiving selective digestive decontamination. The study found that the intestinal load of KPC-Kp decreased rapidly during SDD, but the persistent eradication rate was low after SDD.
Objectives: To monitor quantitatively the extent of intestinal colonisation by KPC-producing Klebsiella pneumoniae (KPC-Kp) in colonised patients who receive selective digestive decontamination (SDD) with oral gentamicin. Methods: We developed a real-time quantitative PCR (qPCR) method for determination of the relative load of blaKPC (RLKPC) within the gut microbiota. Clinical validation was performed using a culture method as the gold standard and receiver operating curve (ROC) analysis. Fifteen patients were observationally and prospectively followed for one year. Clinical, microbiological variables and rectal swab samples were collected at 0 (baseline), 14 and 30 days and monthly thereafter. Results: Clinical validation performed on 111 rectal swab samples demonstrated that the PCR method detected 17% more positives than the culture method. ROC curve analysis documented excellent agreement between both methods (area under the curve, 0.96; 95% confidence interval 0.93-0.99). The RLKPC decreased in 6/15 (40%) and 7/12 (58.3%) patients on days 14 and 30, respectively. Persistent eradication was observed in 2/12 (16.7%), 3/9 (33.3%), 4/8 (50%) and 7/8 (87.5%) patients at 1, 3, 6 and 12 months, respectively, with a median time of 150 days (range 30-270) to persistent eradication. Gentamicin-resistant KPC-Kp isolates were identified in 4/15 (26.7%) patients. The rates of infections (57.1% vs. 12.5%, P = 0.119) and deaths (71.4% vs. 0%, P = 0.007) were higher among patients with high baseline RLKPC. Conclusion: Following SDD, a rapid reduction on intestinal load is observed when the colonising KPC-Kp isolate is susceptible to gentamicin; however, persistent eradication at the end of SDD is low. Intestinal carriage of KPC-Kp persists after three months in about one third of patients. (C) 2022 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据